astragaloside a has been researched along with Cancer of Stomach in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, K; Li, F; Liu, Y; Wang, M; Zhang, Y | 1 |
| Chen, Z; Liu, H; Luo, S; Sha, X; Yang, D | 1 |
| Chen, H; Liu, W; Wang, D | 1 |
| Wen, K; Zhu, J | 1 |
| Cai, D; Cai, T; Chen, Y; Gan, H; Huang, X; Li, S; Pan, H; Zeng, X; Zhang, C; Zhao, Z; Zhuo, J | 1 |
| Cai, D; Cai, H; Cai, T; Chen, X; Li, S; Liu, W; Pan, H; Xie, K; Yan, Y; Zeng, X; Zhang, C; Zhao, Z | 1 |
| Huang, J; Kang, J; OuYang, Y; OuYang, Z | 1 |
1 trial(s) available for astragaloside a and Cancer of Stomach
| Article | Year |
|---|---|
Astragaloside IV reverses MNNG-induced precancerous lesions of gastric carcinoma in rats: Regulation on glycolysis through miRNA-34a/LDHA pathway.
Topics: Animals; Drugs, Chinese Herbal; Glycolysis; Male; Rats; Rats, Sprague-Dawley; Saponins; Stomach Neoplasms; Triterpenes | 2018 |
6 other study(ies) available for astragaloside a and Cancer of Stomach
| Article | Year |
|---|---|
Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)/miR-489-3p/ eukaryotic translation initiation factor 4A1(EIF4A1) pathway.
Topics: Humans; MicroRNAs; Peptide Initiation Factors; RNA, Circular; Saponins; Stomach Neoplasms; Thioctic Acid; Triterpenes | 2022 |
Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts through regulation of the HOXA6/ZBTB12 axis.
Topics: Cancer-Associated Fibroblasts; DNA-Binding Proteins; Genes, Homeobox; Humans; Saponins; Stomach Neoplasms; Transcription Factors; Tumor Microenvironment | 2023 |
Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1.
Topics: B7-H1 Antigen; Cell Line, Tumor; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Human Umbilical Vein Endothelial Cells; Humans; MicroRNAs; Saponins; Stomach Neoplasms; Triterpenes | 2021 |
Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
Topics: Antigens, CD; Cadherins; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Saponins; Signal Transduction; Stomach Neoplasms; Transcription Factor RelA; Transforming Growth Factor beta1; Triterpenes | 2018 |
The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats.
Topics: Adenocarcinoma; Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Gastric Mucosa; Hyperplasia; Metaplasia; Methylnitronitrosoguanidine; Precancerous Conditions; Protective Agents; Rats; Rats, Sprague-Dawley; Saponins; Stomach; Stomach Neoplasms; Triterpenes | 2018 |
Enrichment and purification process of astragalosides and their anti-human gastric cancer MKN-74 cell proliferation effect.
Topics: Adsorption; Astragalus Plant; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Plant Extracts; Porosity; Resins, Synthetic; Saponins; Spectrophotometry, Ultraviolet; Stomach Neoplasms; Triterpenes | 2014 |